NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis announced it has received a €2.5 million ($2.7 million) grant from the Flemish Agency for Innovation & Entrepreneurship (IWT) to expand its manufacturing capacity.
The award comes under the agency's Strategic Transformation Support program and will be used to support manufacturing of the firm's PCR-based Idylla diagnostic platform and assays. Funds will also be used to support training and education for workers at its Mechelen, Belgium facility.